To test this, we used the highly transfectable neuroblastoma cell line neuro-2A (N2A) in experiments with overexpression and inhibition of miR-26a, which demonstrated the expected decrease and increase in GSK3β (Fig. S4F,G). Here, GSK3B is linked to neuroblastoma.